Acute myeloid leukemia is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood. Patients typically experience tiredness, shortness of breath, easy bruising and bleeding, and increased risk of infection, as normal bone marrow is replaced by leukemia cells, causing drops in red blood cells, platelets, and normal white blood cells. The disease progresses rapidly and is fatal within weeks or months if untreated.
Facts
Classification
Body SystemSourced to the subject's own accountLymphatic or Immune System 1 ICD-10 Chapter Communicable or Non-communicable Transmission Route Connections
Treated By
Source 7+3 (chemotherapy) (Wikipedia)
Source FLAG (chemotherapy) (Wikipedia)
Sources
1. Acute myeloid leukemia (Wikipedia)
WikipediaInfobox: fieldQuote, Infobox: field
Hematology, oncology
2. Wikipedia: ICD-10
WikipediaList of chapters, Chapter IIQuote, List of chapters, Chapter II
Neoplasms
3. World Health Organization: Noncommunicable diseases (fact sheet)
World Health OrganizationLead section, transmission-route statement (inferred from disease-category)
The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
Main Types section
The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
View the Source 7+3 (chemotherapy) (Wikipedia)
Treated By: 7+3 (Chemotherapy), Lead section (treats 319775)Quote, Treated By: 7+3 (Chemotherapy), Lead section (treats 319775)
"7+3" in the context of chemotherapy is an acronym for a chemotherapy regimen that is most often used today (as of 2014) as first-line induction therapy (to induce remission) in acute myelogenous leukemia, excluding the acute promyelocytic leukemia form, which is better treated with ATRA and/or arsenic trioxide and requires less chemotherapy (if requires it at all, which is not always the case).
FLAG (chemotherapy) (Wikipedia)
Treated By: FLAG (Chemotherapy), Lead section (treats 319775)Quote, Treated By: FLAG (Chemotherapy), Lead section (treats 319775)
FLAG is a chemotherapy regimen used for relapsed and refractory acute myeloid leukemia (AML).
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.